AMP-945

CAS No. 1393653-34-3

AMP-945( —— )

Catalog No. M28772 CAS No. 1393653-34-3

AMP-945 is a proprietary focal adhesion kinase (FAK) inhibitor.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 236 In Stock
5MG 188 In Stock
10MG 312 In Stock
25MG 534 In Stock
50MG 739 In Stock
100MG 1014 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    AMP-945
  • Note
    Research use only, not for human use.
  • Brief Description
    AMP-945 is a proprietary focal adhesion kinase (FAK) inhibitor.
  • Description
    AMP-945 is a proprietary focal adhesion kinase (FAK) inhibitor.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Angiogenesis
  • Target
    FAK
  • Recptor
    ——
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1393653-34-3
  • Formula Weight
    527.58
  • Molecular Formula
    C28H32F3N5O2
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 100 mg/mL (189.54 mM)
  • SMILES
    CN(CC1)CCC1c(cc1)cc(OC)c1Nc1nc(CCc2c(CC(N)=O)cccc2)c(C(F)(F)F)cn1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Michalakea, Eleftheria; Graikou, Konstantia; Aligiannis, Nektarios; Panoutsopoulos, George; Kalpoutzakis, Eleftherios; Roussakis, Christos; Chinou, Ioanna[Phytochemistry Letters, 2019, vol. 31, p. 155 - 160]
molnova catalog
related products
  • Conteltinib

    CT-707 (Conteltinib) is a novel multikinase inhibitor targeting FAK (IC50=1.6 nM).

  • GSK215

    GSK215 is a potent and selective PROTAC focal adhesion kinase (FAK) degrader (pDC50= 8.4), designed using the FAK inhibitor VS-4718 and a binder for the VHL E3 ligase, capable of inducing rapid and prolonged FAK degradation.

  • Y15

    Y15 is a potent and specificsmall-molecule FAK scaffolding inhibitor that inhibits its autophosphorylation activity blocks tumor growth.